New Chemotherapy Drug for Ovarian Cancer

A new chemotherapy drug for ovarian cancer has received United States Food and Drug Administration (FDA) Orphan Drug Designation. Cantrixil is now scheduled to enter Australia in late-2015/early-2016 for clinical treatment of patients with the condition malignant ascites, a terminal condition associated with cancers such as ovarian cancer and for which no effective long-term therapies exist.

Digital App Technology Benefits the Trauma Room

Trauma specialists at Sydney’s Westmead Hospital have reported a positive response to the six-month trial of a new app designed specifically for the facility to assist with critical decision-making processes in time and resource restricted situations.

A better way to care for patients with cognitive impairment

Review of the National Safety and Quality Health Service Standards - Development of version two

Better Patient Consultation Needed on Funding of Medical Technologies

There needs to be improved consultation with patient advocacy groups about public health funding for new medical technologies according to a study by the University of Adelaide's School of Population Health.

The future health leaders of tomorrow

Improving Medication Safety: Safer Together

Medication safety is a critical issue for health professionals and their patients. Although medicines make a significant contribution to preventing and treating illness, increasing life expectancy and improving quality of life, they also have the potential to cause harm. As a result, medicines are not only associated with providing therapeutic benefits to patients, but also with adverse events caused by errors in systems and processes within prescribing, dispensing, administration and monitoring practices. Medication incidences have negative impacts on patient outcomes and public confidence of healthcare delivery and they are costly to the health care system, its health professionals and regulatory bodies. Safe use of medicines is a high priority in the healthcare sector.

Drop in Golden Staph Cases in Major Australian Hospitals

Australia’s major public hospitals have recorded a six per cent drop in the rate of healthcare-associated ‘Golden Staph’ bloodstream infections.

Vitamin D link with Depression in Overweight Women

University of Adelaide researchers have discovered a previously unknown link between vitamin D and depression in overweight women with polycystic ovary syndrome (PCOS).

Call to Stop Doctors Providing Unproven Stem Cell Therapies

The Australian Academy of Science is calling  for the closure of a loophole that is allowing some doctors to offer unproven stem cell therapies.

Pharmacists need to embrace ehealth

E-Health is harder than it should be

Ethics and hospital design

Nurse leadership important for patient care

Blocking Dengue Fever With Bacteria

Research conducted at the University of Melbourne, in collaboration with international researchers, has tested a novel way to block dengue virus using Wolbachia, an insect bacterium.